369- Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment
questionnaire, disability and pain scales. J Rheumatol. 1982;9(5):789–93. - Pincus T, Summey JA, Soraci Jr SA, Wallston KA, Hummon NP. Assessment of patient
satisfaction in activities of daily living using a modifi ed Stanford Health Assessment
Questionnaire. Arthritis Rheum. 1983;26(11):1346–53. - McHorney CA, Ware Jr JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health
Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse
patient groups. Med Care. 1994;32(1):40–66. - Bird HA, Leeb BF, Montecucco CM, Misiuniene N, Nesher G, Pai S, Pease C, Rovensky J,
Rozman B. A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica.
Ann Rheum Dis. 2005;64(4):626–9. - Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C,
Bachta A, Dejaco C, Duftner C, Jensen HS, et al. 2012 provisional classifi cation criteria for
polymyalgia rheumatica: a European League Against Rheumatism/American College of
Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484–92. - Mackie SL, Hughes R, Walsh M, Day J, Newton M, Pease C, Kirwan J, Morris M. “An impedi-
ment to living life”: why and how should we measure stiffness in polymyalgia rheumatica?
PLoS One. 2015;10(5), e0126758. - Dasgupta B, Salvarani C, Schirmer M, Crowson CS, Maradit-Kremers H, Hutchings A,
Matteson EL, members of the American College of Rheumatology Work Group for
Development of Classifi cation Criteria for PMR. Developing classifi cation criteria for poly-
myalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol.
2008;35(2):270–7. - Leeb BF, Bird HA, Nesher G, Andel I, Hueber W, Logar D, Montecucco CM, Rovensky J,
Sautner J, Sonnenblick M. EULAR response criteria for polymyalgia rheumatica: results of an
initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of
ESCISIT). Ann Rheum Dis. 2003;62(12):1189–94. - Leeb BF, Bird HA. A disease activity score for polymyalgia rheumatica. Ann Rheum Dis.
2004;63(10):1279–83. - Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, Padula A, Boiardi
L. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity
and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis
Rheum. 2000;30(1):17–24. - Castrejon I, Huang A, Everakes SL, Nika A, Sequeira W, Pincus T. Documentation of clinical
improvement in patient with polymyalgia rheumatica according to MDHAQ/RAPID3
(Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index
Data): a longitudinal analysis from routine care. Arthritis Rheum. 2015;67 Suppl 10. - Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a
MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol.
2005;32(8):1432–9. - Castrejon I, Bergman MJ, Pincus T. MDHAQ/RAPID3 to recognize improvement over 2
months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondylo-
arthropathy, and gout, as well as rheumatoid arthritis. J Clin Rheumatol. 2013;19(4):169–74. - van Tuyl LH, Boers M. Patient-reported outcomes in core domain sets for rheumatic diseases.
Nat Rev Rheumatol. 2015;11(12):705–12. - Wells G, Li T, Maxwell L, Maclean R, Tugwell P. Responsiveness of patient reported out-
comes including fatigue, sleep quality, activity limitation, and quality of life following treat-
ment with abatacept for rheumatoid arthritis. Ann Rheum Dis. 2008;67(2):260–5. - Castrejon I, Pincus T. Patient self-report outcomes to guide a treat-to-target strategy in clinical
trials and usual clinical care of rheumatoid arthritis. Clin Exp Rheumatol. 2012;30 Suppl
73:S50–5. - Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for poly-
myalgia rheumatica. Ann Rheum Dis. 1979;38(5):434–9.
14 PROMs for Polymyalgia Rheumatica